A Test and Treat Strategy in New HIV Diagnosis.

PHASE3CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

October 5, 2020

Primary Completion Date

May 11, 2023

Study Completion Date

May 11, 2023

Conditions
HIV-1-infection
Interventions
DRUG

Biktarvy

Once daily fixed dose combination regimen of Biktarvy will be evaluated as a rapid treatment strategy in newly HIV diagnosed patients HIV diagnosed patients that come for the first time to the Hospital Clínic HIV Unit

Trial Locations (1)

08036

Hospital Clínic de Barcelona, Barcelona

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Gilead Sciences

INDUSTRY

lead

Judit Pich Martínez

OTHER